Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Single-dose and preservative-free formulation of Makena launched in the U.S.

April 5, 2016

CHMP recommends approval of Strimvelis for ADA-SCID

April 4, 2016

Amicus' migalastat gets positive opinion from EMA for Fabry disease

April 4, 2016

Guizhou Bailing Group Pharmaceutical discloses alpha-glucosidase inhibitors

April 4, 2016

Celimmune initiates phase II study of AMG-714 for refractory celiac disease type II

April 1, 2016

Radius Health submits NDA for abaloparatide for postmenopausal osteoporosis

March 31, 2016

Eli Lilly describes S6K1 inhibitors

March 31, 2016

OPKO Health receives complete response letter from FDA for calcifediol

March 30, 2016

Bristol-Myers Squibb patents GPR120 agonists

March 30, 2016

Topline phase IIb results for fispemifene in symptomatic secondary hypogonadism

March 30, 2016

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...